|
1
|
Gibcus JH, Tan LP, Harms G, Schakel RN, de
Jong D, Blokzijl T, Möller P, Poppema S, Kroesen BJ and van den
Berg A: Hodgkin lymphoma cell lines are characterized by a specific
miRNA expression profile. Neoplasia. 11:167–176. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Vardiman JW: The World Health Organization
(WHO) classification of tumors of the hematopoietic and lymphoid
tissues: An overview with emphasis on the myeloid neoplasms. Chem
Biol Interact. 184:16–20. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Paydas S, Acikalin A, Ergin M, Celik H,
Yavuz B and Tanriverdi K: Micro-RNA (miRNA) profile in Hodgkin
lymphoma: Association between clinical and pathological variables.
Med Oncol. 33:342016. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Kasinski AL and Slack FJ: Epigenetics and
genetics. MicroRNAs en route to the clinic: Progress in validating
and targeting microRNAs for cancer therapy. Nat Rev Cancer.
11:849–864. 2011. View
Article : Google Scholar : PubMed/NCBI
|
|
5
|
Djuranovic S, Nahvi A and Green R: A
parsimonious model for gene regulation by miRNAs. Science.
331:550–553. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Farazi TA, Hoell JI, Morozov P and Tuschl
T: MicroRNAs in human cancer. Adv Exp Med Biol. 774:1–20. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Lima CR, Gomes CC and Santos MF: Role of
microRNAs in endocrine cancer metastasis. Mol Cell Endocrinol.
456:62–75. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Hemmatzadeh M, Mohammadi H, Karimi M,
Musavishenas MH and Baradaran B: Differential role of microRNAs in
the pathogenesis and treatment of esophageal cancer. Biomed
Pharmacother. 82:509–519. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Jiang Q, He M, Ma MT, Wu HZ, Yu ZJ, Guan
S, Jiang LY, Wang Y, Zheng DD, Jin F, et al: MicroRNA-148a inhibits
breast cancer migration and invasion by directly targeting WNT-1.
Oncol Rep. 35:1425–1432. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Fang JH, Zhou HC, Zeng C, Yang J, Liu Y,
Huang X, Zhang JP, Guan XY and Zhuang SM: MicroRNA-29b suppresses
tumor angiogenesis, invasion, and metastasis by regulating matrix
metalloproteinase 2 expression. Hepatology. 54:1729–1740. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Yuan Y, Kluiver J, Koerts J, de Jong D,
Rutgers B, Abdul Razak FR, Terpstra M, Plaat BE, Nolte IM, Diepstra
A, et al: miR-24-3p is overexpressed in Hodgkin lymphoma and
protects Hodgkin and Reed-Sternberg cells from apoptosis. Am J
Pathol. 187:1343–1355. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Sun X, Xiao D, Xu T and Yuan Y:
miRNA-24-3p promotes cell proliferation and regulates
chemosensitivity in head and neck squamous cell carcinoma by
targeting CHD5. Future Oncol. 12:2701–2712. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Yu G, Jia Z and Dou Z: miR-24-3p regulates
bladder cancer cell proliferation, migration, invasion and
autophagy by targeting DEDD. Oncol Rep. 37:1123–1131. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Hua F, Xue JF, Lü XX and Hu ZW: DEDD
decreases Smad3 activity, promotes tumor cell apoptosis and
inhibits proliferation. Yao Xue Xue Bao. 48:680–685. 2013.(In
Chinese). PubMed/NCBI
|
|
15
|
Carstens JL, Lovisa S and Kalluri R:
Microenvironment-dependent cues trigger miRNA-regulated feedback
loop to facilitate the EMT/MET switch. J Clin Invest.
124:1458–1460. 2014. View
Article : Google Scholar : PubMed/NCBI
|
|
16
|
Lv Q, Hua F and Hu ZW: DEDD, a novel tumor
repressor, reverses epithelial-mesenchymal transition by activating
selective autophagy. Autophagy. 8:1675–1676. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Wang F, Xie X, Yang X, Jiang G and Gu J:
The influence of marital status on the survival of patients with
Hodgkin lymphoma. Oncotarget. 8:51016–51023. 2017.PubMed/NCBI
|
|
19
|
Wang J, Paris PL, Chen J, Ngo V, Yao H,
Frazier ML, Killary AM, Liu CG, Liang H, Mathy C, et al: Next
generation sequencing of pancreatic cyst fluid microRNAs from low
grade-benign and high grade-invasive lesions. Cancer Lett. 356:(2
Pt B). 404–409. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Di Leva G and Croce CM: The role of
microRNAs in the tumorigenesis of ovarian cancer. Front Oncol.
3:1532013. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Ben Dhiab M, Ziadi S, Ksiaa F, Louhichi T,
Ben Gacem R, Ben Zineb A, Amara K, Hachana M and Trimeche M:
Methylation of miR124a-1, miR124a-2, and miR124a-3 in Hodgkin
lymphoma. Tumour Biol. 36:1963–1971. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Qian D, Chen K, Deng H, Rao H, Huang H,
Liao Y, Sun X, Lu S, Yuan Z, Xie D, et al: MicroRNA-374b suppresses
proliferation and promotes apoptosis in T-cell lymphoblastic
lymphoma by repressing AKT1 and Wnt-16. Clin Cancer Res.
21:4881–4891. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Ben Dhiab M, Ziadi S, Louhichi T, Ben
Gacem R, Ksiaa F and Trimeche M: Investigation of miR9-1, miR9-2
and miR9-3 methylation in Hodgkin lymphoma. Pathobiology.
82:195–202. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Slezak-Prochazka I, Kluiver J, de Jong D,
Smigielska-Czepiel K, Kortman G, Winkle M, Rutgers B, Koerts J,
Visser L, Diepstra A, et al: Inhibition of the miR-155 target NIAM
phenocopies the growth promoting effect of miR-155 in B-cell
lymphoma. Oncotarget. 7:2391–2400. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Chhabra R, Dubey R and Saini N:
Cooperative and individualistic functions of the microRNAs in the
miR-23a~27a~24-2 cluster and its implication in human diseases. Mol
Cancer. 9:2322010. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Xu W, Liu M, Peng X, Zhou P, Zhou J, Xu K,
Xu H and Jiang S: miR-24-3p and miR-27a-3p promote cell
proliferation in glioma cells via cooperative regulation of MXI1.
Int J Oncol. 42:757–766. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
Pan B, Chen Y, Song H, Xu Y, Wang R and
Chen L: Mir-24-3p downregulation contributes to VP16-DDP resistance
in small-cell lung cancer by targeting ATG4A. Oncotarget.
6:317–331. 2015. View Article : Google Scholar : PubMed/NCBI
|
